In their recent paper, Song Li and Tatjana C. Jakobs (Harvard Schepens Eye Research Institute) show how they have identified Vitamin C as a potential neuroprotective substance that could be used clinically in patients suffering from glaucoma. Striatech’s OptoDrum was used as readout tool for visual performance.
In this “OptoDrum Applications” video, Dr. Maximiliano Presa from The Jackson Laboratory presents results of his research in a model of Multiple Sulfatase Deficiency (MSD).
Scientists from Harvard Medical School were able to reverse the consequences of aging in the visual system, successfully treating optic nerve injury and glaucoma. Here is an overview of their 2020 study and it´s key findings.
Next week, on October 14th, it is world sight day, themed “#LoveYourEyes”, and the whole of October is blindness awareness month. Both events are meant to guide global attention to vision impairment and blindness, strengthen vision research, and improve access to eyecare worldwide.
Striatech offers new products for research on Myopia, a chronic progressive eye disease. It is estimated that by 2050, almost 50% of the world population will be myopic. But Myopia also leads to numerous secondary eye diseases that can even lead to blindness.
In this recent paper, Françoise Morin et al. show with our OptoDrum that a lack of histamine, unexpectedly, has no impact on the development and severity of Experimental Autoimmune Encephalomyelitis (EAE).
The “Standardization of Uveitis Nomenclature (SUN) Working Group” published classification criteria to help with better disease-specific approaches to diagnosis and treatment. For animal models of Uveitis, our OptoDrum provides a convenient readout tool to characterize diesease progression.
In this video of our series “OptoDrum Applications” Prof. Volker Enzmann from the University of Bern presents the results of his research on induced EAE, a model for optic neuropathy and multiple sclerosis.
In this video, Prof Volker Enzmann highlights an important topic: the relationship between retinal damage and optomotor behavior output is not necessarily linear, and it needs to be established for individual disease models. In the case of laser-induced local retinal damage, the optomotor behavior is only weakly affected, reflecting the surprising robustness of this reflex.
At this year’s ARVO, one of our OptoDrum users – Ms Anna Potenski from Columbia University – is presenting a poster on the topic of “Elucidating endothelial caspase-9 signaling pathways in retinal vein occlusion” containing OptoDrum data.
